Advances in treating acute asthma exacerbations in children

Related Experiment Video

Updated: Jun 23, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Craig M Schramm1, Christopher L Carroll

  • 1Pulmonary Division, Connecticut Children's Medical Center, Hartford, CT 06106, USA. cschram@ccmckids.org

Current Opinion in Pediatrics
|April 24, 2009
PubMed

Insights

Effective asthma management in children involves symptom-based action plans and preferred delivery methods like metered-dose inhalers. Recognizing risk factors and utilizing advanced treatments can significantly improve outcomes for pediatric asthma exacerbations.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Clinical Therapeutics

Background:

  • Asthma is a prevalent chronic respiratory disease in children, frequently leading to acute exacerbations.
  • While core asthma exacerbation therapies remain consistent, novel approaches are emerging.
  • Recent advancements focus on medication delivery, self-management, and identifying severe exacerbation risk factors.

Purpose of the Study:

  • To review recent advancements in the management of acute asthma exacerbations in children.
  • To highlight improved therapeutic outcomes through updated treatment strategies.
  • To discuss the role of risk factor identification and patient self-management.

Main Methods:

  • Review of recent scientific literature on pediatric asthma exacerbation management.
  • Analysis of studies comparing different medication delivery systems and action plan strategies.
  • Evaluation of emerging risk factors and novel treatment modalities.

Main Results:

  • Symptom-based written action plans demonstrate greater efficacy than peak expiratory flow-based plans.
  • Metered-dose inhalers are increasingly preferred for mild-to-moderate exacerbations in emergency settings.
  • High-dose inhaled corticosteroids show comparable effectiveness to oral corticosteroids for acute exacerbations.
  • Combination therapy with budesonide and formoterol offers a novel maintenance and relief strategy.
  • Obesity and genetic variations are identified as contributors to severe exacerbations.
  • Noninvasive positive pressure ventilation is an emerging option for severe cases.

Conclusions:

  • Optimized management strategies can substantially enhance outcomes for children experiencing asthma exacerbations.
  • Continued research into novel therapies and personalized risk assessment is crucial for pediatric asthma care.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: